Additionally, long sleep duration could be associated with increased odds of being reliably symptomatic at 4 weeks.

Take a quick look at everything you may have missed last month, including the top FDA approvals and latest clinical updates.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from June 2025.

The updated labeling includes a new contraindication for patients with prior or active hepatic events.